Skip to content

NTHI NTHI Operating Income

Operating Income at other companies

Nuvectis Pharma, Inc. logo
Nuvectis Pharma, Inc.NVCT
-$6.26M-12.4%
Oric Pharmaceuticals, Inc. logo
Oric Pharmaceuticals, Inc.ORIC
-$39.62M-21.1%
Crinetics Pharmaceuticals logo
Crinetics PharmaceuticalsCRNX
-$140.38M-26.0%

Other financials

Income statement

See full
Revenue$40.0K-7.0%
Net income-$8.8M+72.7%
EPS (diluted)-$0.38+78.7%

Balance sheet

See full
Cash & equivalents$138.6K-97.5%
Total debt$666.1K
Total equity-$13.2M-37.5%
Total assets$3.3M-60.6%

Cash flow

See full
Operating cash flow-$7.0M-23.7%
CapEx$125.0K
Free cash flow-$5.2M

Valuation

See full
Market cap$114.62M+51.0%
Enterprise value$115.15M+51.1%
P/S1,432.9×

Profitability

See full
Operating margin-46,870.7%
Net margin-51,613.3%
FCF margin-26,083.2%

Returns & leverage

See full
Return on equity338.1%
Debt / equity-0.1×
Current ratio0.1×-0.3×

Where this comes from

Reported directly by NTHI in its filing.

Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.

The official record: NTHI’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about NTHI's operating income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is NTHI's operating income?
NTHI (NTHI) reported operating income of -$7.06M in Q1 2026.
How has NTHI's operating income changed year-over-year?
NTHI's operating income increased by 77.9% year-over-year, from -$31.9M to -$7.06M.
What does operating income mean?
Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.